Dinesh Kumar,Saurabh Srivastava,Indranil Nandi,Rakesh K. Singh,Amit Jha,Kamal S. Mehta
申请号：
US16827534
公开号：
US20200222420A1
申请日:
2020.03.23
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to orally administered liquid pharmaceutical compositions of eslicarbazepine. The liquid compositions are in the form of ready to use suspension and suspension powder for reconstitution. It also relates to the processes for the preparation of said liquid compositions. The present invention provides liquid compositions of eslicarbazepine with desired technical attributes such as release profile and pH. The prepared compositions are useful in patients having difficulties in swallowing tablets and provide physician with providing a more convenient and less cumbersome posology.
